nmdp logo

Navigating HLA-Matched and Mismatched Graft Sources

On-demand panel discussion link


This session includes an in-depth discussion on the current science supporting the selection of HLA-matched and mismatched donors. Experts from across the transplant and cell therapy community will explore recent research into the identification of permissive matches.

They'll discuss strategies for minimizing negative impacts of mismatching by using innovative transplant approaches in the adult and pediatric settings. You"II will gain a better understanding of HLA- and non-HLA factors to consider when selecting the optimal graft source for each patient.

Learning Objectives

Viewers of this session will grow their knowledge and understanding of:

  • Current science supporting HLA-matched and mismatched donors
  • Recent research on the identification of permissive matches
  • Minimizing negative impacts of mismatching
  • HLA and non-HLA factors to consider when selection a graft source

Target Audience

Coordinators, physicians, medical directors


  • Bronwen Shaw, MD, PhD, Chief Scientific Director, CIBMTR® (Center for International Blood and Marrow Transplant Research®)
  • Stephanie Lee, MD, MPH, David and Patricia Giuliani/Oliver Press Endowed Chair in Cancer Research, Fred Hutchinson Cancer Research Center, University of Washington
  • Effie Petersdorf, MD, Professor of Medicine, University of Washington and Fred Hutchinson Cancer Research Center
  • Eric Davis, MPH, CHTC, Program Manager, BMT Unrelated Donor Search Program, Memorial Sloan Kettering
  • Muna Qayed, MD, MsCR, Director, Blood and Marrow Transplantation Program, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University